Biomarker Technologies Publishes DNA Sequencing Technology Comparison
Biomarker Technologies has released a guide for selecting DNA sequencing technologies in 2026. The publication covers accuracy, speeds, and operational costs of various platforms.
Biomarker Technologies (BMKGene) has published a comprehensive guide to assist global buyers in selecting the most suitable DNA sequencing technology for 2026. The publication emphasizes that technology selection requires consideration beyond mere technical specifications, including data accuracy, workflow stability, data security, and overall costs.
The guide reviews various sequencing platforms, encompassing short-read, long-read, single-cell, and portable systems. It compares prominent providers such as Illumina, Oxford Nanopore, PacBio, and MGI, assessing their suitability for diverse fields including clinical work, agriculture, and industry. Short-read technologies are noted for their accuracy in variant detection, while long-read systems are highlighted for their capability to identify complex genomic regions and structural variations.
BMKGene advises that the selection process should also incorporate practical aspects such as sample preparation time, reagent availability, software compatibility, and the importance of local support. The utility of portable devices in field settings is also discussed, alongside a caution regarding potential environmental influences on results.
The company stresses that no single platform is universally ideal for all laboratories. The guide encourages buyers to compare independently validated results and real-world performance, rather than relying solely on marketing claims. High-quality and transparent quality control processes are also considered crucial for informed decision-making.